Article
A mutation in Mycobacterium tuberculosis rpoB gene confers rifampin resistance in three HIV-TB cases.
Tuberculosis (Edinburgh, Scotland) - 1 Mar 2010
Malhotra Sangita, Cook Victoria J, Wolfe Joyce N, Tang Patrick, Elwood Kevin, Sharma Meenu K
Abstract excerpt
Rifampin is a key component of standard short-course first-line therapy against Mycobacterium tuberculosis (MTB). Rifampin monoresistant MTB, previously a rare phenomenon, is now being reported at increasing rates worldwide. We report a mutation in the rpoB region leading to low level rifampin mo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
